TOP NEWS

Axonics Modulation Technologies Sets Estimated IPO Range

Irvine-based Axonics Modulation Technologies, a developer of medical devices for treating urinary and bowel dysfunction, has set its estimated IPO range, ahead of its expected IPO this week. The startup, which is venture backed by BioDiscovery, Longitude Venture Partners, Cooperatieve Gilde Healthcare, the Alfred E. Mann Foundation, and others,

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.